Bixiye
QP44-18 Pharmacy Benefit Update - New Drug-Related PA with QL Criteria: Lyrica CR (pregabalin Extended Release)
Taariikhda wax ku ool ah ee barnaamijka: Jun 06, 2018
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2961 - 2970 ee natiijooyinka 3289
Bixiye
QP41-18 Addition of Drugs to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Taariikhda wax ku ool ah ee barnaamijka: Jun 06, 2018
Bixiye
QP46-18 Change to Call Center for Transportation for MHCP Members
Taariikhda wax ku ool ah ee barnaamijka: Jun 06, 2018
Bixiye
QP42-18 Addition of Drugs to the Cystic Fibrosis Transmembrane Conductance Regulator PA with QL Program
Taariikhda wax ku ool ah ee barnaamijka: Jun 06, 2018
Bixiye
QP43-18 Addition of Drugs to the Oral Immunotherapy PA with QL Program
Taariikhda wax ku ool ah ee barnaamijka: Jun 06, 2018
Bixiye
QP45-18 Pharmacy Benefit Update - New Drug-Related PA with QL Criteria: Xermelo (telotristat)
Taariikhda wax ku ool ah ee barnaamijka: Jun 06, 2018
Bixiye
QP39-18 Provider Cost Data Update
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2018
Bixiye
P23-18 Clinical Reviews for Court-Ordered Substance Use Disorder Treatment
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2018
Bixiye
P25-18 eviCore Healthcare Specialty Utilization Management (UM)
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2018
Bixiye
P24-18 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial Lines of Business - Effective August 6, 2018
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2018